pentetic acid has been researched along with Carcinoma, Medullary in 21 studies
Pentetic Acid: An iron chelating agent with properties like EDETIC ACID. DTPA has also been used as a chelator for other metals, such as plutonium.
Carcinoma, Medullary: A carcinoma composed mainly of epithelial elements with little or no stroma. Medullary carcinomas of the breast constitute 5%-7% of all mammary carcinomas; medullary carcinomas of the thyroid comprise 3%-10% of all thyroid malignancies. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1141; Segen, Dictionary of Modern Medicine, 1992)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Analysis of dose-response curves at days 20 and 40 showed additivity between RIT and paclitaxel, and analysis at day 60 suggested a synergistic effect." | 1.31 | Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft. ( Barbet, J; Campion, L; Chatal, JF; Chérel, M; Faivre-Chauvet, A; Kraeber-Bodéré, F; Mirallié, E; Saï-Maurel, C; Supiot, S; Thédrez, P, 2002) |
| "Patients had a history of thyroid cancer or of carcinoid tumor." | 1.30 | Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne. ( Delisle, MJ; Liehn, JC; Pérault, C; Schvartz, C; Wampach, H, 1997) |
| "Patient 1 had a metastatic follicular thyroid carcinoma, patient 2 a metastatic medullary thyroid carcinoma, patient 3 tuberculosis and patient 4 an insulinoma." | 1.30 | Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide. ( Breeman, WA; Krenning, EP; Kwekkeboom, DJ; van Hagen, PM; Visser, TJ, 1998) |
| "In patients with carcinoids, a combination of somatostatin receptor scintigraphy, chest radiograph and ultrasound of the upper abdomen had a high sensitivity for tumor localization, and detected lesions in patients in whom no tumor was found with conventional imaging, justifying the greater cost." | 1.29 | Cost-effectiveness analysis of somatostatin receptor scintigraphy. ( Habbema, JD; Krenning, EP; Kwekkeboom, DJ; Lamberts, SW, 1996) |
| "In midgut carcinoid (MC) patients (all scintigraphy positive), 4/29 macroscopically identified tumours gave false R(in situ)." | 1.29 | Radioisotope-guided surgery in patients with neuroendocrine tumours. ( Ahlman, H, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 15 (71.43) | 18.2507 |
| 2000's | 6 (28.57) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kraeber-Bodéré, F | 3 |
| Saï-Maurel, C | 3 |
| Campion, L | 3 |
| Faivre-Chauvet, A | 2 |
| Mirallié, E | 1 |
| Chérel, M | 1 |
| Supiot, S | 1 |
| Barbet, J | 4 |
| Chatal, JF | 4 |
| Thédrez, P | 3 |
| Béhé, M | 1 |
| Becker, W | 1 |
| Gotthardt, M | 1 |
| Angerstein, C | 1 |
| Behr, TM | 1 |
| Gao, Z | 1 |
| Biersack, HJ | 2 |
| Ezziddin, S | 1 |
| Logvinski, T | 1 |
| An, R | 2 |
| Gao, ZR | 1 |
| Zhang, YX | 1 |
| Berná, L | 1 |
| Cabezas, R | 1 |
| Mora, J | 1 |
| Torres, G | 1 |
| Estorch, M | 1 |
| Carrió, I | 1 |
| Eising, EG | 1 |
| Farahati, J | 1 |
| Bier, D | 1 |
| Knust, EJ | 1 |
| Reiners, C | 1 |
| Dörr, U | 1 |
| Sautter-Bihl, ML | 1 |
| Bihl, H | 1 |
| Kwekkeboom, DJ | 3 |
| Lamberts, SW | 1 |
| Habbema, JD | 1 |
| Krenning, EP | 3 |
| Baudin, E | 1 |
| Lumbroso, J | 1 |
| Schlumberger, M | 1 |
| Leclere, J | 1 |
| Giammarile, F | 1 |
| Gardet, P | 1 |
| Roche, A | 1 |
| Travagli, JP | 1 |
| Parmentier, C | 1 |
| Ahlman, H | 1 |
| Kurtaran, A | 2 |
| Leimer, M | 1 |
| Kaserer, K | 2 |
| Yang, Q | 1 |
| Angelberger, P | 2 |
| Niederle, B | 2 |
| Virgolini, I | 2 |
| Horn, JD | 1 |
| Gordon, BM | 1 |
| Gordon, L | 1 |
| Spicer, KM | 1 |
| Pérault, C | 1 |
| Schvartz, C | 1 |
| Wampach, H | 1 |
| Liehn, JC | 1 |
| Delisle, MJ | 1 |
| Breeman, WA | 1 |
| van Hagen, PM | 1 |
| Visser, TJ | 1 |
| Shi, W | 1 |
| Johnston, CF | 1 |
| Buchanan, KD | 1 |
| Ferguson, WR | 1 |
| Laird, JD | 1 |
| Crothers, JG | 1 |
| McIlrath, EM | 1 |
| Peltier, P | 1 |
| Bardet, S | 1 |
| Vuillez, JP | 1 |
| Bachelot, I | 1 |
| Denet, S | 1 |
| Olivier, P | 1 |
| Leccia, F | 1 |
| Corcuff, B | 1 |
| Huglo, D | 1 |
| Proye, C | 1 |
| Rouvier, E | 1 |
| Meyer, P | 1 |
| Scheuba, C | 1 |
| Schima, W | 1 |
| Czerny, C | 1 |
| Faibre-Chauvet, A | 1 |
| Gautherot, E | 2 |
| Fiche, M | 2 |
| Le Boterff, J | 2 |
| Bakker, WH | 1 |
| Kooij, PP | 1 |
| Erion, J | 1 |
| Srinivasan, A | 1 |
| de Jong, M | 1 |
| Reubi, JC | 1 |
| Cuccurullo, V | 1 |
| Cascini, GL | 1 |
| Rambaldi, PF | 1 |
| Mansi, L | 1 |
1 review available for pentetic acid and Carcinoma, Medullary
| Article | Year |
|---|---|
[Role of somatostatin analogs in the treatment of neuroendocrine tumours].
Topics: Adrenal Gland Neoplasms; Adrenalectomy; Antineoplastic Agents, Hormonal; Carcinoma, Medullary; Carci | 2001 |
5 trials available for pentetic acid and Carcinoma, Medullary
| Article | Year |
|---|---|
Improved kinetic stability of DTPA- dGlu as compared with conventional monofunctional DTPA in chelating indium and yttrium: preclinical and initial clinical evaluation of radiometal labelled minigastrin derivatives.
Topics: Animals; Carcinoma, Medullary; Cell Line, Tumor; Chelating Agents; Drug Evaluation, Preclinical; Dru | 2003 |
The role of combined imaging in metastatic medullary thyroid carcinoma: 111In-DTPA-octreotide and 131I/123I-MIBG as predictors for radionuclide therapy.
Topics: 3-Iodobenzylguanidine; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Rad | 2004 |
[Targeted radionuclide therapy for patients with metastatic medullary thyroid carcinoma].
Topics: 3-Iodobenzylguanidine; Adult; Aged; Antineoplastic Agents; Carcinoma, Medullary; Female; Follow-Up S | 2006 |
Combined use of 111In-DTPA-D-Phe-1-octreotide (OCT) and 123I-vasoactive intestinal peptide (VIP) in the localization diagnosis of medullary thyroid carcinoma (MTC).
Topics: Adult; Aged; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Iodine Radioisotopes; Male; | 1996 |
Radioimmunodetection of medullary thyroid carcinoma using indium-111 bivalent hapten and anti-CEA x anti-DTPA-indium bispecific antibody.
Topics: Adult; Aged; Antibodies, Bispecific; Biomarkers, Tumor; Carcinoembryonic Antigen; Carcinoma, Medulla | 1998 |
15 other studies available for pentetic acid and Carcinoma, Medullary
| Article | Year |
|---|---|
Enhanced antitumor activity of combined pretargeted radioimmunotherapy and paclitaxel in medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Carcinoembryonic Antigen; Carcinoma, Medullary; Combined Modality T | 2002 |
111In-octreotide and 99mTc(V)-dimercaptosuccinic acid studies in the imaging of recurrent medullary thyroid carcinoma.
Topics: Adult; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Female; Humans; Male; Middle Aged; Neopl | 1995 |
[Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoid Tumor; Carcinoma, Medullary; False Posi | 1995 |
The contribution of somatostatin receptor scintigraphy to the diagnosis of recurrent medullary carcinoma of the thyroid.
Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Female; Gene Expression Regulation, Neopl | 1994 |
Cost-effectiveness analysis of somatostatin receptor scintigraphy.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Carcinoma, Small Cell; Cost-Benefit Analysis; Costs and Cost | 1996 |
Comparison of octreotide scintigraphy and conventional imaging in medullary thyroid carcinoma.
Topics: Adult; Aged; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Liver Neoplasms; Male; Midd | 1996 |
Radioisotope-guided surgery in patients with neuroendocrine tumours.
Topics: Carcinoid Tumor; Carcinoma, Medullary; Humans; Indium Radioisotopes; Neuroendocrine Tumors; Octreoti | 1996 |
Octreotide uptake in the head and neck.
Topics: Carcinoma, Medullary; Diagnosis, Differential; Female; Head and Neck Neoplasms; Humans; Indium Radio | 1997 |
Thoracic and abdominal SPECT-CT image fusion without external markers in endocrine carcinomas. The Group of Thyroid Tumoral Pathology of Champagne-Ardenne.
Topics: 3-Iodobenzylguanidine; Abdominal Neoplasms; Carcinoid Tumor; Carcinoma, Medullary; Feasibility Studi | 1997 |
Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
Topics: Adenocarcinoma, Follicular; Adult; Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Insul | 1998 |
Localization of neuroendocrine tumours with [111In] DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging.
Topics: Adolescent; Adult; Aged; Carcinoid Tumor; Carcinoma, Medullary; Child; Female; Humans; Indium Radioi | 1998 |
Indium-111-DTPA-D-Phe-1-octreotide and technetium-99m-(V)-dimercaptosuccinic acid scanning in the preoperative staging of medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Female; Humans; Indium Radioisotopes; Lymph Nodes; Lymphatic Metastasis; Male; | 1998 |
Bispecific antibody and bivalent hapten radioimmunotherapy in CEA-producing medullary thyroid cancer xenograft.
Topics: Animals; Antibodies, Bispecific; Antibodies, Monoclonal; Carcinoembryonic Antigen; Carcinoma, Medull | 1999 |
Toxicity and efficacy of radioimmunotherapy in carcinoembryonic antigen-producing medullary thyroid cancer xenograft: comparison of iodine 131-labeled F(ab')2 and pretargeted bivalent hapten and evaluation of repeated injections.
Topics: Animals; Carcinoembryonic Antigen; Carcinoma, Medullary; Haptens; Humans; Immunoglobulin Fab Fragmen | 1999 |
Cholecystokinin receptor imaging using an octapeptide DTPA-CCK analogue in patients with medullary thyroid carcinoma.
Topics: Carcinoma, Medullary; Humans; Indium Radioisotopes; Pentetic Acid; Radionuclide Imaging; Receptor, C | 2000 |